Zimmer Biomet Holdings Inc 's Cash & cash equivalent grew by 163.46 % in the Q1 2025 sequentially, while Current Liabilities decreased, this led to improvement in Zimmer Biomet Holdings Inc 's Quick Ratio to 0.6, above Zimmer Biomet Holdings Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 41 other companies have achieved higher Quick Ratio than Zimmer Biomet Holdings Inc in first quarter 2025. While Quick Ratio total ranking has improved so far during the Q1 2025 to 747, from total ranking in the fourth quarter 2024 at 2132.

Explain Quick Ratio?
How much Cash & cash equivalents ZBH´s has?
What are ZBH´s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

ZBH Quick Ratio	(Mar 31 2025) Q1	(Dec 31 2024) Q4	(Sep 30 2024) Q3	(Jun 30 2024) Q2	(Mar 31 2024) Q1
Y / Y Current Liabilities Change	-17.95 %	-14.23 %	72.4 %	61.54 %	19.74 %
Y / Y Cash & cash equivalent Change	252.29 %	26.38 %	94.8 %	31.36 %	19.02 %
Quick Ratio MRQ	0.6	0.21	0.16	0.12	0.14
ZBH's Total Ranking	# 747	# 2132	# 555	# 3306	# 0
Seq. Current Liabilities Change	-6.37 %	-31.37 %	-1.03 %	29.01 %	-2.11 %
Seq. Cash & cash equivalent Change	163.46 %	-7.64 %	35.44 %	6.9 %	-5.48 %

New: More ZBH's historic Quick Ratios >>

Quick Ratio first quarter 2025 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 42
Healthcare Sector	# 227
Overall Market	# 747

Quick Ratio Statistics
High	Average	Low
1.75	0.36	0.11
(Dec 31 2013)		(Jun 30 2019)

Financial Statements
Zimmer Biomet Holdings Inc 's Current Liabilities	$ 2,295 Millions	Visit ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Cash & cash equivalent	$ 1,385 Millions	Visit ZBH's Balance sheet
Source of ZBH's Sales		Visit ZBH's Sales by Geography

Cumulative Zimmer Biomet Holdings Inc 's Quick Ratio

ZBH's Quick Ratio for the trailling 12 Months

ZBH Quick Ratio	(Mar 31 2025) 12 Months	(Dec 31 2024) 12 Months	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	19.74 %	30.84 %	42.61 %	22.89 %	5.35 %
Y / Y Cash & cash equivalent TTM Growth	104.06 %	40.48 %	36.43 %	-3.19 %	-13.25 %
Quick Ratio TTM	0.24	0.15	0.14	0.13	0.14
Total Ranking TTM	# 2650	# 1382	# 3466	# 2577	# 0
Seq. Current Liabilities TTM Growth	-4.04 %	-3.17 %	13.23 %	13.8 %	4.85 %
Seq. Cash & cash equivalent TTM Growth	51.98 %	6.1 %	18.21 %	7.06 %	4.62 %

Quick ratio ranking by company, industry and sector >> Back to ZBH Financial Strength Comparisons >> Go to Compare ZBH Quick Ratio to its Competitors

On the trailing twelve months basis ZBH Cash & cash equivalent more than doubled by 252.29 % in Q1 2025 year on year, while Current Liabilities decreased to $2,295 millions, this led to increase in in Zimmer Biomet Holdings Inc 's Quick Ratio to 0.24, Quick Ratio remained below ZBH average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 138 other companies have achieved higher Quick Ratio than Zimmer Biomet Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2024 from 1382 to 2650.

Explain Quick Ratio?
How much Cash & cash equivalents ZBH´s has?
What are ZBH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 139
Healthcare Sector	# 713
Within the Market	# 2650

trailing twelve months Quick Ratio Statistics
High	Average	Low
0.46	0.24	0.13
(Dec 31 2020)		(Jun 30 2024)

Companies with similar Quick Ratio in the quarter ending Mar 31 2025, within Medical Equipment & Supplies Industry	Quick Ratio	Mar 31 2025 MRQ Cash & cash equivalent	Mar 31 2025 MRQ Current Liabilities
Atricure Inc	1.63	$ 99.885 Millions	$ 61.221 Millions
Orthopediatrics Corp	1.57	$ 58.772 Millions	$ 37.505 Millions
Sanara Medtech Inc	1.56	$ 20.688 Millions	$ 13.281 Millions
Dariohealth Corp	1.46	$ 28.046 Millions	$ 19.155 Millions
Harvard Apparatus Regenerative Technology Inc	1.45	$ 1.728 Millions	$ 1.195 Millions
Tandem Diabetes Care Inc	1.44	$ 368.625 Millions	$ 256.485 Millions
Cadre Holdings inc	1.42	$ 133.431 Millions	$ 93.666 Millions
Novocure Limited	1.42	$ 929.131 Millions	$ 654.056 Millions
Sharps Technology Inc	1.38	$ 11.895 Millions	$ 8.649 Millions
Sonoma Pharmaceuticals Inc	1.31	$ 5.374 Millions	$ 4.096 Millions
Envista Holdings Corporation	1.23	$ 1,077.300 Millions	$ 873.300 Millions
Cytosorbents Corporation	1.19	$ 11.587 Millions	$ 9.736 Millions
Cerus Corporation	1.16	$ 80.919 Millions	$ 69.690 Millions
Safe Pro Group Inc	1.15	$ 0.912 Millions	$ 0.791 Millions
Avita Medical Inc	1.12	$ 25.818 Millions	$ 22.956 Millions
Axogen inc	1.12	$ 22.069 Millions	$ 19.658 Millions
Koru Medical Systems Inc	1.12	$ 8.736 Millions	$ 7.799 Millions
Trisalus Life Sciences Inc	1.11	$ 13.000 Millions	$ 11.753 Millions
Ss Innovations International Inc	1.06	$ 15.873 Millions	$ 14.997 Millions
Rosecliff Acquisition Corp I	1.06	$ 14.061 Millions	$ 13.312 Millions
Electrocore Inc	1.04	$ 7.759 Millions	$ 7.492 Millions
Neuronetics Inc	1.02	$ 20.224 Millions	$ 19.919 Millions
Establishment Labs Holdings Inc	1.00	$ 69.178 Millions	$ 69.038 Millions
Privia Health Group Inc	1.00	$ 469.331 Millions	$ 468.424 Millions
Neuraxis Inc	1.00	$ 2.026 Millions	$ 2.028 Millions
Livanova Plc	1.00	$ 738.437 Millions	$ 741.573 Millions
Resmed Inc	0.99	$ 932.711 Millions	$ 940.516 Millions
Plus Therapeutics Inc	0.93	$ 9.867 Millions	$ 10.559 Millions
Nuwellis Inc	0.93	$ 2.557 Millions	$ 2.749 Millions
Lensar Inc	0.93	$ 25.247 Millions	$ 27.174 Millions

Date modified: 2025-05-06T07:42:26+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com